CTEV vs LEN · rev $930.6M vs rev $34.19B
Claritev Corporation (CTEV) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Claritev Corporation (CTEV) is a health information services company listed on US.
LEN (LEN) common stock.
Latest reported CTEV revenue for 2024-12-31 was $930.6M. Net income was -$1.65B. Revenue was down 3.2% from 2023-12-31 to 2024-12-31. CTEV currently screens at market cap $440.5M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CTEV currently screens at market cap $440.5M. LEN currently screens at market cap $0.
Not investment advice. Open the CTEV and LEN stock pages for the full models.
Not investment advice.